Comparison of Pentraxin-3 in Migraine Patients without Aura and Healthy Controls

Authors

  • Maham Tahir
  • Mariyam Khan
  • Shazia Ramzan Sialkot Medical College, Sialkot
  • Mehwish Qamar
  • Maira Tahir
  • Adnan Ali
  • Hafiz Muhammad Usman

DOI:

https://doi.org/10.59058/jaimc.v21i4.138

Keywords:

migraine, pentraxin-3, endothelial dysfunction, C-reactive protein (CRP)

Abstract

Background and Objectives: Migraine is a common cerebrovascular condition marked by one-sided, pulsating headache, which may or may not be accompanied with an aura. Migraine is mostly found in females who are of childbearing age. One of the speculated mechanisms for the pathophysiology of migraine is endothelial dysfunction. A new biomarker of inflammatory disorders, pentraxin-3 is often produced by endothelium injury. In earlier investigations, it was shown that migraine sufferers had elevated levels of pentraxin-3. Our study's objectives were to analyze the serum pentraxin-3 levels in migraine sufferers without aura and healthy controls.
Methods: It was a cross-sectional comparative study. This was done at the IMBB Department, University of Lahore, Lahore Pakistan, from March 2020 to April 2022. We took 40 diagnosed migraine cases and 40 healthy controls. Detailed examination was done and proformas were filled by both cases and controls. Serum was collected by each of them and pentraxin-3 values were determined by using specific Elisa kits. SPSS version 22 was used for statistical analysis. For normality of data Shapiro wilk test was used. Mann whiteny U test was used for the comparision of means of pentraxin-3 in migrainers and healthy controls.
Results: The data were non-normally distributed after the Shapiro-Wilk Test. The average age of the controls was 25±6.06 years, while that of individuals with migraines was 26±7.78 years. Patients with migraine were mostly women. The majority of the patients had BMI category 18 to 24.5. Patients with migraine had mean pentraxin-3 levels of 145.75 ±157.7 pg/l, compared to 43.65 ±33.01 pg/l in the control group. Median was
100.5 in cases and 31.15 in controls. P-value was 0.0001.
Conclusion: When compared to the control group, migraine patients had considerably higher blood levels of PTX-3, and no correlations between age, BMI, marital status, smoking history, and usage of preventative medications were found.
Key words: migraine, pentraxin-3, endothelial dysfunction, C-reactive protein (CRP),

 

Downloads

Published

03-05-2024

How to Cite

Tahir, M., Khan, M., Shazia Ramzan, Qamar, M., Tahir, M., Ali, A., & Usman, H. M. (2024). Comparison of Pentraxin-3 in Migraine Patients without Aura and Healthy Controls. JAIMC: Journal of Allama Iqbal Medical College, 21(4). https://doi.org/10.59058/jaimc.v21i4.138